Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 150
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 151
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
LATEST NEWS UPDATES | ICMR ready to offer Covaxin know-how to other firms -Monika Yadav

ICMR ready to offer Covaxin know-how to other firms -Monika Yadav

Share this article Share this article
published Published on May 7, 2021   modified Modified on May 12, 2021

-The Hindu Business Line

It’s only an open-ended deal with co-developer Bharat Biotech, says top source

The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended.

Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR’s Pune-based National Institute of Virology (NIV).

An official involved with the developments told BusinessLine that the terms and conditions agreed upon while transferring the Covid-19 vaccine technology was that Bharat Bio will pay the ICMR 5 per cent royalty on the net sales of Covaxin.

“The contract with Bharat Biotech is not close-ended, it is open-ended in terms of sharing of technology. So, we are free to share the know-how with other companies. Currently, we are entitled to get 5 per cent royalty from Bharat Biotech on an annual basis,” the source said.

Asked if any company has approached the ICMR for the vaccine technology, the source declined to comment but reiterated that it was well within its rights to give the technology to others.

As India opened up vaccination for people in the 18-44 age group, the country is facing a serious supply shortage with the two manufacturers expressing their inability to ramp up production substantially to meet the demand.

PSUs brought in

The government has roped in a few public sector undertakings (PSUs) involved in vaccine production such as Haffkine Biopharmaceutical Corporation (owned by the Maharashtra government), Indian Immunological Limited (owned by the National Dairy Development Board), and Bharat Immunologicals and Biologicals Limited (under the Department of Biotechnology) to make Covaxin.

Please click here to read more.


The Hindu Business Line, 7 May, 2021, https://www.thehindubusinessline.com/news/icmr-ready-to-offer-covaxin-know-how-to-other-firms/article34501232.ece?fbclid=IwAR2rVJojRi2RUlIWDbrdAcaP-nwXsJiyErUgFzvjdOXD5WWlXV1S4OEpfYQ


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close